Ivosidenib: First Global Approval (vol 78, pg 1509, 2018)

被引：0

|

作者：

Dhillon, Sohita ^{[1
]}

机构：

[1] Springer, Private Bag 65901, Auckland 0754, New Zealand

来源：

DRUGS | 2019年 / 79卷 / 01期

关键词：

D O I：

10.1007/s40265-018-1050-z

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：107 / 107

页数：1

相关论文

共 50 条

[1] Caplacizumab: First Global Approval (vol 78, pg 1638, 2018)
Duggan, Sean
[J]. DRUGS, 2018, 78 (18) : 1955 - 1955
[2] Fremanezumab: First Global Approval (vol 78, pg 1829, 2018)
Hoy, Sheridan M.
[J]. DRUGS, 2019, 79 (05) : 585 - 585
[3] Anlotinib: First Global Approval (vol 78, pg 1057, 2018)
Syed, Yahiya Y.
[J]. DRUGS, 2018, 78 (12) : 1287 - 1287
[4] Ibalizumab: First Global Approval(vol 78, pg 781, 2018)
Markham, Anthony
[J]. DRUGS, 2018, 78 (08) : 859 - 859
[5] Elagolix: First Global Approval (vol 78, pg 1501, 2018)
Lamb, Yvette N.
[J]. DRUGS, 2018, 78 (17) : 1855 - 1855
[6] Moxetumomab Pasudotox: First Global Approval (vol 78, pg 1763, 2018)
Dhillon, Sohita
[J]. DRUGS, 2019, 79 (01) : 105 - 105
[7] Andexanet Alfa: First Global Approval (vol 78, pg 1049, 2018)
Heo, Young-A
[J]. DRUGS, 2018, 78 (12) : 1285 - 1285
[8] Ivosidenib: First Global Approval
Sohita Dhillon
[J]. Drugs, 2018, 78 : 1509 - 1516
[9] Ivosidenib: First Global Approval
Dhillon, Sohita
[J]. DRUGS, 2018, 78 (14) : 1509 - 1516
[10] Correction to: Ivosidenib: First Global Approval
Sohita Dhillon
[J]. Drugs, 2019, 79 (1) : 107 - 107

← 1 2 3 4 5 →